Huanle Pan

Wenzhou, 325000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Development and validation of a small extracellular vesicle-derived RNA signature for early diagnosis of lung adenocarcinoma and prognosis in advanced stages.

Development and validation of a small extracellular vesicle-derived RNA signature for early diagnosis of lung adenocarcinoma and prognosis in advanced stages.

Journal: Molecular cancer

Published: June 03, 2025

Proteome-wide analysis reveals potential therapeutic targets for Colorectal cancer: a two-sample mendelian randomization study.

Proteome-wide analysis reveals potential therapeutic targets for Colorectal cancer: a two-sample mendelian randomization study.

Journal: BMC cancer

Published: August 10, 2023

Mutual communication between radiosensitive and radioresistant esophageal cancer cells modulates their radiosensitivity.

Mutual communication between radiosensitive and radioresistant esophageal cancer cells modulates their radiosensitivity.

Journal: Cell death & disease

Published: June 03, 2023

Efficacy of apatinib+radiotherapy vs radiotherapy alone in patients with advanced multiline therapy failure for non small cell lung cancer with brain metastasis.

Efficacy of apatinib+radiotherapy vs radiotherapy alone in patients with advanced multiline therapy failure for non small cell lung cancer with brain metastasis.

Journal: The British journal of radiology

Published: May 10, 2023

Regorafenib activates oxidative stress by inhibiting SELENOS and potentiates oxaliplatin-induced cell death in colon cancer cells.

Regorafenib activates oxidative stress by inhibiting SELENOS and potentiates oxaliplatin-induced cell death in colon cancer cells.

Journal: European journal of pharmacology

Published: March 30, 2023

Isoalantolactone Enhances the Antitumor Activity of Doxorubicin by Inducing Reactive Oxygen Species and DNA Damage.

Isoalantolactone Enhances the Antitumor Activity of Doxorubicin by Inducing Reactive Oxygen Species and DNA Damage.

Journal: Frontiers in oncology

Published: November 12, 2021

Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways.

Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: October 07, 2021

The Predictive Value of MLR for Radiation Pneumonia During Radiotherapy of Thoracic Tumor Patients.

The Predictive Value of MLR for Radiation Pneumonia During Radiotherapy of Thoracic Tumor Patients.

Journal: Cancer management and research

Published: June 23, 2020

Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.

Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 25, 2017

Profiling and bioinformatics analyses reveal differential circular RNA expression in radioresistant esophageal cancer cells.

Profiling and bioinformatics analyses reveal differential circular RNA expression in radioresistant esophageal cancer cells.

Journal: Journal of translational medicine

Published: March 31, 2016

FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R.

FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R.

Journal: Journal of translational medicine

Published: November 17, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026